Clinical Trials Browser

Phase 2 × Leukemia, Lymphocytic, Chronic, B-Cell × VAP-cyclo protocol × Clear all

NCT00072007 2012-05-15

Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell